Antje Margret Wengner

Person

Berlin, DE

People

Patents Grantslast 30 patents

Information Patent Grant
Compounds, compositions and methods for cancer patient stratificati...
- Patent number 12,053,476
- Issue date Aug 6, 2024
- Bayer Pharma Aktiengesellschaft
- Timothy A. Lewis
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Inhibitor of ATR kinase for use in a method of treating a hyper-pro...
- Patent number 11,976,334
- Issue date May 7, 2024
- Bayer Aktiengesellschaft
- Antje Margret Wengner
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Predictive markers for ATR kinase inhibitors
- Patent number 11,712,440
- Issue date Aug 1, 2023
- Bayer Aktiengesellschaft
- Antje Margret Wengner
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Combination of ATR kinase inhibitors and PD-1/PD-L1 inhibitors
- Patent number 11,690,911
- Issue date Jul 4, 2023
- Bayer Aktiengesellschaft
- Antje Margret Wengner
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Combination of ATR kinase inhibitors with PARP inhibitors
- Patent number 11,660,301
- Issue date May 30, 2023
- Bayer Pharma Aktiengesellschaft
- Antje Margret Wengner
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
2-(morpholin-4-yl)-1,7-naphthyridines
- Patent number 11,529,356
- Issue date Dec 20, 2022
- Bayer Pharma Aktiengesellschaft
- Lars Wortmann
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compounds, compositions and methods for cancer treatment
- Patent number 11,142,522
- Issue date Oct 12, 2021
- The Broad Institute, Inc.
- Timothy A. Lewis
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds, compositions and methods for cancer patient stratificati...
- Patent number 10,966,986
- Issue date Apr 6, 2021
- Bayer Pharma Aktiengesellschaft
- Timothy A. Lewis
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Heteroarylbenzimidazole compounds
- Patent number 10,894,784
- Issue date Jan 19, 2021
- Bayer Pharma Aktiengesellschaft
- Volker Schulze
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
2-(morpholin-4-yl)-1,7-naphthyridines
- Patent number 10,772,893
- Issue date Sep 15, 2020
- Bayer Pharma Aktiengesellschaft
- Lars Wortmann
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
5-substituted 2-(morpholin-4-yl)-1,7-naphthyridines
- Patent number 10,729,680
- Issue date Aug 4, 2020
- Bayer Pharma Aktiengesellschaft
- Ulrich Lücking
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted benzylindazoles for use as BUB1 kinase inhibitors in th...
- Patent number 10,604,532
- Issue date Mar 31, 2020
- Bayer Intellectual Property GmbH
- Marion Hitchcock
- A01 - AGRICULTURE FORESTRY ANIMAL HUSBANDRY HUNTING TRAPPING FISHING
Information Patent Grant
Substituted benzylindazoles for use as Bub1 kinase inhibitors in th...
- Patent number 10,266,548
- Issue date Apr 23, 2019
- Bayer Intellectual Property GmbH
- Marion Hitchcock
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Use of substituted 2,3-dihydroimidazo[1,2-C]quinazolines for treati...
- Patent number 10,226,469
- Issue date Mar 12, 2019
- Bayer Pharma Aktiengesellschaft
- Ningshu Liu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Amido-substituted imidazopyridazines useful in the treatment of hyp...
- Patent number 10,214,545
- Issue date Feb 26, 2019
- Bayer Pharma Aktiengesellschaft
- Volker Schulze
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Use of substituted 2,3-dihydroimidazo[1,2-c]quinazolines for treati...
- Patent number 9,999,623
- Issue date Jun 19, 2018
- Bayer Pharma Aktiengesellschaft
- Ningshu Liu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
2-(morpholin-4-yl)-1,7-naphthyridines
- Patent number 9,993,484
- Issue date Jun 12, 2018
- Bayer Pharma Aktiengesellschaft
- Lars Wortmann
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Amino-substituted isothiazoles
- Patent number 9,682,995
- Issue date Jun 20, 2017
- Bayer Pharma Aktiengesellschaft
- Lars Bärfacker
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Triazolopyridines
- Patent number 9,676,766
- Issue date Jun 13, 2017
- Bayer Intellectual Property GmbH
- Volker Schulze
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Substituted triazolopyridines
- Patent number 9,670,202
- Issue date Jun 6, 2017
- Bayer Pharma Aktiengesellschaft
- Hartmut Schirok
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Substituted triazolopyridines and their use as TTK inhibitors
- Patent number 9,663,510
- Issue date May 30, 2017
- Bayer Pharma Aktiengesellschaft
- Volker Schulze
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Prodrug derivatives of substituted triazolopyridines
- Patent number 9,586,958
- Issue date Mar 7, 2017
- Bayer Pharma Aktiengesellschaft
- Volker Schulze
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Substituted triazolopyridines
- Patent number 9,555,022
- Issue date Jan 31, 2017
- Bayer Intellectual Property GmbH
- Volker Schulze
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
2-(morpholin-4-yl)-1,7-naphthyridines
- Patent number 9,549,932
- Issue date Jan 24, 2017
- Bayer Pharma Aktiengesellschaft
- Lars Wortmann
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Thienopyrimidines
- Patent number 9,540,392
- Issue date Jan 10, 2017
- Bayer Pharma Aktiengesellschaft
- Georg Kettschau
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Substituted imidazopyridazines
- Patent number 9,512,130
- Issue date Dec 6, 2016
- Bayer Pharma Aktiengesellschaft
- Marcus Koppitz
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Substituted imidazopyridazines
- Patent number 9,512,126
- Issue date Dec 6, 2016
- Bayer Intellectual Property GmbH
- Marcus Koppitz
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Substituted benzylindazoles for use as Bub1 kinase inhibitors in th...
- Patent number 9,265,763
- Issue date Feb 23, 2016
- Bayer Intellectual Property GmbH
- Marion Hitchcock
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Substituted imidazopyridazines
- Patent number 9,255,100
- Issue date Feb 9, 2016
- Bayer Intellectual Property GmbH
- Ulrich Klar
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Substituted triazolopyridines
- Patent number 8,551,980
- Issue date Oct 8, 2013
- Bayer Intellectual Property GmbH
- Volker Schulze
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
COMPOUNDS, COMPOSITIONS AND METHODS FOR CANCER PATIENT STRATIFICATI...
- Publication number 20240366620
- Publication date Nov 7, 2024
- BAYER PHARMA AKTIENGESELLSCHAFT
- TIMOTHY A. LEWIS
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MAP4K1 INHIBITORS
- Publication number 20240174683
- Publication date May 30, 2024
- Bayer Aktiengesellschaft
- Ulrich LÜCKING
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
LRRC15 ANTIBODIES AND CONJUGATES THEREOF
- Publication number 20240108766
- Publication date Apr 4, 2024
- Bayer Aktiengesellschaft
- Mark TRAUTWEIN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
2-Methyl-Quinazolines
- Publication number 20240083857
- Publication date Mar 14, 2024
- BAYER PHARMA AKTIENGESELLSCHAFT
- Lars WORTMANN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION of ATR KINASE INHIBITORS and PD-1/PD-L1 INHIBITORS
- Publication number 20230346927
- Publication date Nov 2, 2023
- Bayer Aktiengesellschaft
- Antje Margret WENGNER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PYRAZOLOPYRAZINES ACTING ON CANCERS VIA INHIBITION OF CDK12
- Publication number 20230192700
- Publication date Jun 22, 2023
- Bayer Aktiengesellschaft
- Markus BERGER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PYRAZOLOTRIAZINES
- Publication number 20230117034
- Publication date Apr 20, 2023
- Bayer Aktiengesellschaft
- Kai THEDE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
IMIDAZOTRIAZINES ACTING ON CANCER VIA INHIBITION OF CDK12
- Publication number 20230106032
- Publication date Apr 6, 2023
- Bayer Aktiengesellschaft
- Kai THEDE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
2-METHYL-AZA-QUINAZOLINES
- Publication number 20220274979
- Publication date Sep 1, 2022
- BAYER PHARMA AKTIENGESELLSCHAFT
- Lars WORTMANN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMBINATIONS OF INHIBITORS OF IRAK4 WITH INHIBITORS OF BTK
- Publication number 20220241261
- Publication date Aug 4, 2022
- BAYER PHARMA AKTIENGESELLSCHAFT
- Ulrich BOTHE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
2-METHYL-QUINAZOLINES
- Publication number 20220235013
- Publication date Jul 28, 2022
- BAYER PHARMA AKTIENGESELLSCHAFT
- Lars WORTMANN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
THE ATR KINASE INHIBITOR BAY1895344 FOR USE IN THE TREATMENT OF A H...
- Publication number 20220117973
- Publication date Apr 21, 2022
- Bayer Aktiengesellschaft
- Dennis KRICKAU
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INHIBITOR OF ATR KINASE FOR USE IN A METHOD OF TREATING A HYPER-PRO...
- Publication number 20210404012
- Publication date Dec 30, 2021
- Bayer Aktiengesellschaft
- Antje Margret WENGNER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION OF ATR KINASE INHIBITORS WITH 2,3-DIHYDROIMIDAZO[1,2-C]...
- Publication number 20210369724
- Publication date Dec 2, 2021
- Bayer Aktiengesellschaft
- Antje Margret WENGNER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOUNDS, COMPOSITIONS AND METHODS FOR CANCER PATIENT STRATIFICATI...
- Publication number 20210236504
- Publication date Aug 5, 2021
- BAYER PHARMA AKTIENGESELLSCHAFT
- TIMOTHY A. LEWIS
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMBINATION OF ATR KINASE INHIBITORS AND PD-1/PD-L1 INHIBITORS
- Publication number 20210128723
- Publication date May 6, 2021
- BAYER PHARMA AKTIENGESELLSCHAFT
- Antje Margret WENGNER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION OF ATR KINASE INHIBITORS WITH PARP INHIBITORS
- Publication number 20210128572
- Publication date May 6, 2021
- BAYER PHARMA AKTIENGESELLSCHAFT
- Antje Margret WENGNER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
2-(MORPHOLIN-4-YL)-1,7-NAPHTHYRIDINES
- Publication number 20200383991
- Publication date Dec 10, 2020
- BAYER PHARMA AKTIENGESELLSCHAFT
- Lars Wortmann
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PREDICTIVE MARKERS FOR ATR KINASE INHIBITORS
- Publication number 20200375997
- Publication date Dec 3, 2020
- Bayer Aktiengesellschaft
- Antje Margret WENGNER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
AN INHIBITOR OF ATR KINASE FOR USE IN A METHOD OF TREATING A HYPER-...
- Publication number 20200063212
- Publication date Feb 27, 2020
- Bayer Aktiengesellschaft
- Antje Margret WENGNER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOUNDS, COMPOSITIONS AND METHODS FOR CANCER TREATMENT
- Publication number 20200062741
- Publication date Feb 27, 2020
- THE BROAD INSTITUTE, INC.
- TIMOTHY A. LEWIS
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATIONS OF INHIBITORS OF IRAK4 WITH INHIBITORS OF BTK
- Publication number 20190388410
- Publication date Dec 26, 2019
- BAYER PHARMA AKTIENGESELLSCHAFT
- Ulrich BOTHE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOUNDS, COMPOSITIONS AND METHODS FOR CANCER PATIENT STRATIFICATI...
- Publication number 20190365770
- Publication date Dec 5, 2019
- BAYER PHARMA AKTIENGESELLSCHAFT
- TIMOTHY A. LEWIS
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SUBSTITUTED BENZYLINDAZOLES FOR USE AS BUB1 KINASE INHIBITORS IN TH...
- Publication number 20190284206
- Publication date Sep 19, 2019
- Bayer Intellectual Property GmbH
- Marion HITCHCOCK
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
5-SUBSTITUTED 2-(MORPHOLIN-4-YL)-1,7-NAPHTHYRIDINES
- Publication number 20190142812
- Publication date May 16, 2019
- BAYER PHARMA AKTIENGESELLSCHAFT
- Ulrich LÜCKING
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HETEROARYLBENZIMIDAZOLE COMPOUNDS
- Publication number 20190047980
- Publication date Feb 14, 2019
- BAYER PHARMA AKTIENGESELLSCHAFT
- Volker SCHULZE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATIONS OF INHIBITORS OF IRAK4 WITH INHIBITORS OF BTK
- Publication number 20180289685
- Publication date Oct 11, 2018
- BAYER PHARMA AKTIENGESELLSCHAFT
- Ulrich BOTHE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
2-(MORPHOLIN-4-YL)-1,7-NAPHTHYRIDINES
- Publication number 20180256591
- Publication date Sep 13, 2018
- BAYER PHARMA AKTIENGESELLSCHAFT
- Lars Wortmann
- C07 - ORGANIC CHEMISTRY
Information Patent Application
USE OF SUBSTITUTED 2,3-DIHYDROIMIDAZO[1,2-C]QUINAZOLINES FOR TREATI...
- Publication number 20180193349
- Publication date Jul 12, 2018
- BAYER PHARMA AKTIENGESELLSCHAFT
- Ningshu LIU
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOUNDS FOR THE TREATMENT OF CANCER
- Publication number 20170342064
- Publication date Nov 30, 2017
- BAYER PHARMA AKTIENGESELLSCHAFT
- Volker SCHULZE
- C07 - ORGANIC CHEMISTRY

Antje Margret Wengner

Person

Patents Grantslast 30 patents

Compounds, compositions and methods for cancer patient stratificati...

Inhibitor of ATR kinase for use in a method of treating a hyper-pro...

Predictive markers for ATR kinase inhibitors

Combination of ATR kinase inhibitors and PD-1/PD-L1 inhibitors

Combination of ATR kinase inhibitors with PARP inhibitors

2-(morpholin-4-yl)-1,7-naphthyridines

Compounds, compositions and methods for cancer treatment

Compounds, compositions and methods for cancer patient stratificati...

Heteroarylbenzimidazole compounds

2-(morpholin-4-yl)-1,7-naphthyridines

5-substituted 2-(morpholin-4-yl)-1,7-naphthyridines

Substituted benzylindazoles for use as BUB1 kinase inhibitors in th...

Substituted benzylindazoles for use as Bub1 kinase inhibitors in th...

Use of substituted 2,3-dihydroimidazo[1,2-C]quinazolines for treati...

Amido-substituted imidazopyridazines useful in the treatment of hyp...

Use of substituted 2,3-dihydroimidazo[1,2-c]quinazolines for treati...

2-(morpholin-4-yl)-1,7-naphthyridines

Amino-substituted isothiazoles

Triazolopyridines

Substituted triazolopyridines

Substituted triazolopyridines and their use as TTK inhibitors

Prodrug derivatives of substituted triazolopyridines

Substituted triazolopyridines

2-(morpholin-4-yl)-1,7-naphthyridines

Thienopyrimidines

Substituted imidazopyridazines

Substituted imidazopyridazines

Substituted benzylindazoles for use as Bub1 kinase inhibitors in th...

Substituted imidazopyridazines

Substituted triazolopyridines

Patents Applicationslast 30 patents

COMPOUNDS, COMPOSITIONS AND METHODS FOR CANCER PATIENT STRATIFICATI...

MAP4K1 INHIBITORS

LRRC15 ANTIBODIES AND CONJUGATES THEREOF

2-Methyl-Quinazolines

COMBINATION of ATR KINASE INHIBITORS and PD-1/PD-L1 INHIBITORS

PYRAZOLOPYRAZINES ACTING ON CANCERS VIA INHIBITION OF CDK12

PYRAZOLOTRIAZINES

IMIDAZOTRIAZINES ACTING ON CANCER VIA INHIBITION OF CDK12

2-METHYL-AZA-QUINAZOLINES

COMBINATIONS OF INHIBITORS OF IRAK4 WITH INHIBITORS OF BTK

2-METHYL-QUINAZOLINES

THE ATR KINASE INHIBITOR BAY1895344 FOR USE IN THE TREATMENT OF A H...

INHIBITOR OF ATR KINASE FOR USE IN A METHOD OF TREATING A HYPER-PRO...

COMBINATION OF ATR KINASE INHIBITORS WITH 2,3-DIHYDROIMIDAZO[1,2-C]...

COMPOUNDS, COMPOSITIONS AND METHODS FOR CANCER PATIENT STRATIFICATI...

COMBINATION OF ATR KINASE INHIBITORS AND PD-1/PD-L1 INHIBITORS

COMBINATION OF ATR KINASE INHIBITORS WITH PARP INHIBITORS

2-(MORPHOLIN-4-YL)-1,7-NAPHTHYRIDINES

PREDICTIVE MARKERS FOR ATR KINASE INHIBITORS

AN INHIBITOR OF ATR KINASE FOR USE IN A METHOD OF TREATING A HYPER-...

COMPOUNDS, COMPOSITIONS AND METHODS FOR CANCER TREATMENT

COMBINATIONS OF INHIBITORS OF IRAK4 WITH INHIBITORS OF BTK

COMPOUNDS, COMPOSITIONS AND METHODS FOR CANCER PATIENT STRATIFICATI...

SUBSTITUTED BENZYLINDAZOLES FOR USE AS BUB1 KINASE INHIBITORS IN TH...

5-SUBSTITUTED 2-(MORPHOLIN-4-YL)-1,7-NAPHTHYRIDINES

HETEROARYLBENZIMIDAZOLE COMPOUNDS

COMBINATIONS OF INHIBITORS OF IRAK4 WITH INHIBITORS OF BTK

2-(MORPHOLIN-4-YL)-1,7-NAPHTHYRIDINES

USE OF SUBSTITUTED 2,3-DIHYDROIMIDAZO[1,2-C]QUINAZOLINES FOR TREATI...

COMPOUNDS FOR THE TREATMENT OF CANCER